Tan Hooi Min Grahn

Tan Hooi Min Grahn

Auto-generated profile, based on publicly available information

Tan Hooi Min Grahn

Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University Hospital, 22184, Lund, Sweden

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TGTan Hooi Min Grahn
Tan Hooi Min Grahn
YZYan Zhang
Yan Zhang
MLMi-Jeong Lee
Mi-Jeong Lee
ASAndreia Gianotti Sommer
Andreia Gianotti Sommer
GMGustavo Mostoslavsky
Gustavo Mostoslavsky
VPVishwajeet Puri
Vishwajeet Puri

1 April 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TGTan Hooi Min Grahn
Tan Hooi Min Grahn
RKRajween Kaur
Rajween Kaur
JYJun Yin
Jun Yin
MSMartina Schweiger
Martina Schweiger
VSVishva Mitra Sharma
Vishva Mitra Sharma
VPVishwajeet Puri
Vishwajeet Puri
In adipocytes, lipolysis is a highly regulated process involving hormonal signals, lipid droplet-associated proteins, and lipases. The discovery of new lipid droplet-associated proteins added complexity to the current model of lipolysis. In this study, we used cultured human adipocytes to demonstrate that fat-specific protein 27 (FSP27), an abundantly expressed protein in adipocytes, regulates both basal and stimulated lipolysis by interacting with adipose triglyceride lipase (ATGL, also called desnutrin or PNPLA2). We identified a core domain of FSP27, amino acids 120–220, that interacts with ATGL to inhibit its lipolytic function and promote triglyceride storage. We also defined the role of FSP27 in free fatty acid-induced insulin resistance in adipocytes. FSP27 depletion in human adipocytes increased lipolysis and inhibited insulin signaling by decreasing AKT phosphorylation. However, reducing lipolysis by either depletion of ATGL or expression of exogenous full-length FSP27 or amino acids 120–220 protected human adipocytes against the adverse effects of free fatty acids on insulin signaling. In embryonic fibroblasts derived from ATGL KO mice, exogenous free fatty acids did not affect insulin sensitivity. Our results demonstrate a crucial role for FSP27-ATGL interactions in regulating lipolysis, triglyceride accumulation, and insulin signaling in human adipocytes.

20 June 2016 in Liver International
Verified
Journal Article
Closed access
PDF file
YZYihu Zheng
Yihu Zheng
WHWei‐Jian Hu
Wei‐Jian Hu
BCBi‐Cheng Chen
Bi‐Cheng Chen
TGTan‐Hooi‐Min Grahn
Tan‐Hooi‐Min Grahn
YZYan‐Rong Zhao
Yan‐Rong Zhao
QZQi‐Yu Zhang
Qi‐Yu Zhang

10 February 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LLLifang Luo
Lifang Luo
WSWenjing Sun
Wenjing Sun
WZWeijian Zhu
Weijian Zhu
SLShuhan Li
Shuhan Li
WZWenqi Zhang
Wenqi Zhang
YZYihu Zheng
Yihu Zheng
Cisplatin is one of the most effective chemotherapy drugs and is widely used in the treatment of cancer, including hepatocellular carcinoma (HCC) and cervical cancer, but its therapeutic benefit is limited by the development of resistance. Our previous studies demonstrated that BCAT1 promoted cell proliferation and decreased cisplatin sensitivity in HCC cells. However, the exact role and mechanism of how BCAT1 is involved in cisplatin cytotoxicity remain undefined. In this study, we revealed that cisplatin triggered autophagy in cancer cells, with an increase in BCAT1 expression. The cisplatin-induced up-regulation of BCAT1 decreased the cisplatin sensitivity by regulating autophagy through the mTOR signaling pathway. In addition, branched-chain amino acids or leucine treatment inhibited cisplatin- or BCAT1-mediated autophagy and increased cisplatin sensitivity by activating mTOR signaling in cancer cells. Moreover, inhibition of autophagy by chloroquine increased cisplatin sensitivity in vivo. Also, the knockdown of BCAT1 or the administration of leucine activated mTOR signaling, inhibited autophagy, and increased cisplatin sensitivity in cancer cells in vivo. These findings demonstrate a new mechanism, revealing that BCAT1 decreases cisplatin sensitivity in cancer cells by inducing mTOR-mediated autophagy via branched-chain amino acid leucine metabolism, providing an attractive pharmacological target to improve the effectiveness of chemotherapy.

1 February 2009 in Development
Verified
Journal Article
Open access
PDF file
ISIna Strate
Ina Strate
TMTan H. Min
Tan H. Min
DIDobromir Iliev
Dobromir Iliev
EPEdgar M. Pera
Edgar M. Pera
Retinoic acid (RA) is an important morphogen that regulates many biological processes, including the development of the central nervous system (CNS). Its synthesis from vitamin A (retinol) occurs in two steps, with the second reaction - catalyzed by retinal dehydrogenases (RALDHs) - long considered to be crucial for tissue-specific RA production in the embryo. We have recently identified the Xenopus homologue of retinol dehydrogenase 10 (XRDH10) that mediates the first step in RA synthesis from retinol to retinal. XRDH10 is specifically expressed in the dorsal blastopore lip and in other domains of the early embryo that partially overlap with XRALDH2 expression. We show that endogenous RA suppresses XRDH10 gene expression, suggesting negative-feedback regulation. In mRNA-injected Xenopus embryos, XRDH10 mimicked RA responses, influenced the gene expression of organizer markers, and synergized with XRALDH2 in posteriorizing the developing brain. Knockdown of XRDH10 and XRALDH2 by specific antisense morpholino oligonucleotides had the opposite effects on organizer gene expression, and caused a ventralized phenotype and anteriorization of the brain. These data indicate that the conversion of retinol into retinal is a developmentally controlled step involved in specification of the dorsoventral and anteroposterior body axes, as well as in pattern formation of the CNS. We suggest that the combinatorial gene expression and concerted action of XRDH10 and XRALDH2 constitute a `biosynthetic enzyme code' for the establishment of a morphogen gradient in the embryo.

4 March 2014 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
YZYihu Zheng
Yihu Zheng
LYLi‐Hui Yin
Li‐Hui Yin
TGTan Hooi Min Grahn
Tan Hooi Min Grahn
AYAi‐Fang Ye
Ai‐Fang Ye
YZYan‐Rong Zhao
Yan‐Rong Zhao
QZQi‐Yu Zhang
Qi‐Yu Zhang